Skip to content

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis

Bacterial Decolonization to Prevent Radiation-induced Oral Mucositis: A Randomized Controlled Trial and Quality of Life Assessment

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05893810
Enrollment
176
Registered
2023-06-08
Start date
2023-07-01
Completion date
2024-12-31
Last updated
2024-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nasopharyngeal Carcinoma, Radiation-induced Oral Mucositis, Bacterial Colonization, Quality of Life

Brief summary

The purpose of this study is to determine whether bacterial decolonization of the nares prior to treatment with radiotherapy (RT) for patients with nasopharyngeal carcinoma, can prevent high-grade radiation-induced oral mucositis (RIOM) and improve quality of life. This study is being conducted because a randomized clinical trials form Yana Kost et al. have found bacterial decolonization in the nose prior to initiation of RT was effective for prevention of acute radiation dermatitis. Patients in the treatment arm will receive pretreatment with mupirocin ointment to the nares while patients in the control arm will receive standard of care treatment. Bacterial cultures will be taken from the nares and mouth, and participants will also complete a quality of life questionnaire before and after RT.

Interventions

Patients in the intervention arm will receive a decolonization regimen, consisting of intranasal mupirocin ointment to be applied twice daily to the nares

Sponsors

Jiangxi Provincial Cancer Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Patients with newly histologically confirmed nasopharyngeal carcinoma 2. No evidence of distant metastasis (M0) 3. ECOG (Eastern Cooperative OncologyGroup) scale 0-1 4. 18-70 years old

Exclusion criteria

1. Previous or existing mental or cognitive impairment; 2. Patients with other malignant tumors at the same time; 3. Have received bacterial decolonization therapy; 4. Oral mucositis or ulcers existed before radiotherapy. 5. Prior RT to the region of interest

Design outcomes

Primary

MeasureTime frameDescription
High-grade radiation-induced oral mucositisradiation-induced oral mucositis(graded by the RTOG) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)Grade 3 or higher radiation-induced oral mucositis according to RTOG

Secondary

MeasureTime frameDescription
High-grade radiation dermatitisRadiation dermatitis (graded by the CTCAE) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)Grade 3 or higher radiation-induced dermatitis according to RTOG
Quality of Life according QLQ-H&N43Quality of Life (according QLQ-H&N43) will be assessed at the last treatment session (study week depends on patient's length of treatment, but ranges from 6 weeks to 8 weeks)EORTC QLQ-H&N43

Countries

China

Contacts

Primary ContactTianzhu Lu, PhD
lutianzhu2008@163.com8615270186250

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026